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Abstract
Herein, we report total syntheses of the tetramethyldihydroxanthene natural product 
rhodomyrtosone B and the related bis-furan β-triketone natural product rhodomyrtosone A. 
Nickel-(II)-catalyzed 1,4-conjugate addition of an α-alkylidene-β-dicarbonyl substrate was 
developed to access the congener rhodomyrtosone B, and oxygenation of the same 
monoalkylidene derivative followed by cyclization was employed to obtain the bis-furan natural 
product rhodomyrtosone A.
INTRODUCTION
Rhodomyrtone A (1) and its isomer rhodomyrtosone B (2) are derived from the plant 
Rhodomyrtus Tomentosa found in Thailand (Figure 1).1,2 These natural products present 
interesting synthetic challenges due to the presence of a highly oxygenated β-triketone 
moiety fused to an acylphloroglucinol which is present in both isomers. In rhodomyrtone A 
(1), the ether linkage is para to the acyl group, while in rhodomyrtosone B (2), it is ortho. 
Rhodomyrtosone A (3) was also isolated from the Rhodomyrtus genus and possesses an 
intriguing bis-furan acylphloroglucinol core.2,3 Recently, the related natural product 
watsonianone B (4) was isolated from the plant Corymbia watsonia.4 Rhodomyrtone A (1) 
and rhodomyrtosone B (2) were found to be potent antibiotics against Gram-positive 
bacteria including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus 
(MRSA), and several Streptococcus strains (MIC = 4 and 16 µg/mL, respectively).5 
Watsonianone B (4) possesses antimalarial properties by inhibiting the growth of 
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chloroquine sensitive (3D7) and resistant (Dd2) strains of Plasmodium falciparum 
displaying IC50 values of 0.44 and 0.29 µM, respectively.4 Accordingly, these interesting 
structures and highly relevant biological activities make rhodomyrtosones A (3) and B (2) 
appealing synthetic targets. The Maier laboratory6 recently achieved syntheses of 
compounds 1 and 2 adopting a similar strategy developed by Jauch and co-workers for the 
synthesis of myrtucommulone A.7 In this paper, we report a strategy involving nickel(II)-
catalyzed 1,4-conjugate addition to an α-alkylidene-β-dicarbonyl substrate to selectively 
access rhodomyrtosone B (2) and oxygenation of the same monoalkylidene derivative to 
obtain the bis-furan congener rhodomyrtosone A (3).
RESULTS AND DISCUSSION
In our retrosynthetic analysis, we envisioned that rhodomyrtone A (1), rhodomyrtosone B 
(2), and rhodomyrtosone A (3) could be synthesized from a common starting material in a 
divergent manner (Figure 2). Selective dehydrative cyclizations of intermediate 5 could be 
used to access both rhodomyrtone A (1) and rhodomyrtosone B (2). Intermediate 5 may 
arise from conjugate addition of the known acylphloroglucinol 78 to monoalkylidene 6. In 
accordance with the proposed biosynthesis for rhodomyrtosone A,2 natural product 3 may be 
obtained from acylphloroglucinol 7 and endoperoxide 8 after bis-furan formation. 
Endoperoxide 8 may arise from [4 + 2] cycloaddition of oxygen with a dienol intermediate 
that may be obtained via photoenolization of monoalkylidene 6 (Figure 2).9
Our synthetic efforts began with the synthesis of monoalkylidene reaction partner 6 (Scheme 
1). Treatment of syncarpic acid 10,6 isovaleraldehyde, and pyrrolidine (diethyl ether, 0 °C) 
afforded the Mannich product 9 (90%). Acid-mediated elimination of 9 cleanly afforded 
monoalkylidene 6 (75% yield). We next examined a range of catalysts for 1,4-conjugate 
addition10 of acylphloroglucinol 7 to enone 6. A reaction conducted without catalyst 
provided a 9% yield of adduct 5 along with a significant amount of the endoperoxide 
byproduct 8 (stereochemistry unassigned) (Table 1, entry 1). The latter compound may be 
derived from [4 + 2] cycloaddition between the dienol tautomer of 6 and triplet oxygen 
(Table 1, entry 1) (vide infra).11–13 In the presence of YbCl3 or FeCl3, a moderate amount of 
5 was isolated, albeit in low selectivity (Table 1, entries 2 and 3). Rare-earth metal triflate 
catalysts were also investigated; however, these reactions resulted in low yields and 
selectivity (Table 1, entries 4–6).10a We also investigated metal perchlorate salts, which 
have previously been used in 1,4-conjugate additions.14 Cu(ClO4)2, Mg(ClO4)2, and 
Zn(ClO4)2 did not result in significant amounts of adduct 5 (Table 1, entries 7–9). 
Additionally, it was found that Pd (II) catalysis was not effective for this transformation 
(Table 1, entry 10). Ni(ClO4)2 proved to be an effective catalyst, affording a 4.6:1 ratio of 
compounds 5:8 in 74% isolated yield (Table 1, entry 11). Using a 5:1 mixture of CH2Cl2 
and acetic acid as solvent led to an increased yield of the desired adduct 5 (Table 1, entry 
12). Moreover, thorough degassing of solvent eliminated the production of endoperoxide 8 
(Table 1, entry 13) and provided adduct 5 in 90% yield. A control screen using the same 
catalysts as listed in Table 1 with degassed CH2Cl2 was also conducted. Although degassing 
the solvent alleviated the formation of 8, the isolated yields remained low (Table 1, entries 
2, 6–8) except when Ni(ClO4)2·6H2O was employed as catalyst. Based on the results 
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highlighted in Table 1, Ni(ClO4)2·6H2O was identified as a promising catalyst for conjugate 
addition.15
Upon characterization by 1H NMR analysis in CDCl3, we observed that the adduct 5 existed 
as a mixture of two atropisomers in a 2.4:1 ratio at room temperature. The tight hydrogen-
bond network existing within the structure may hinder free rotation generating two 
rotational conformers in equilibrium at room temperature (Figure 3).16 Variable-temperature 
NMR studies were performed to determine the coalescence temperature for 5 that was found 
to be 60 °C, which corresponds to a rotational barrier of 15 kcal/mol.17 A single X-ray 
crystal structure analysis of compound 5 was obtained which further highlights the strong 
internal hydrogen-bond network between the acylphloroglucinol and vinylogous acid 
segments (Figure 3).
We anticipated that adduct 5 could be utilized to achieve dehydrative cyclizations to afford 
natural products 1 and 2 (vida supra). Under acidic conditions, we observed exclusive 
formation of rhodomyrtosone B 2 via dehydrative cyclization of the phenol ortho to the acyl 
group (Scheme 2).6 After considerable optimization, it was found that treatment of 5 in the 
carbocation-stabilizing protic solvent hexafluoroisopropanol (HFIP)18 with added 
trifluoroacetic acid (60 °C, 12 h) afforded rhodomyrtosone B (2) in 42% yield (Scheme 3). 
Our proposed mechanism for selective dehydrative cyclization leading to rhodomyrtosone B 
(2) is shown in Scheme 3. Protonation of vinylogous acid 5 leads to the vinyl oxocarbenium 
intermediate 11 which may exist in equilibrium with its atropisomer 12. We believe that 
hydrogen bonding between the ortho-phenol and the ketone within the acyl substituent 
renders the ortho-phenol more nucleophilic by increasing the electron density of the 
phenolic oxygen.19 Cyclization of 12 to hemiacetal 13 followed by dehydration affords 
rhodomyrtosone B (2). Hemiacetal 13 is likely a relevant intermediate in the proposed 
mechanism as this structural motif exists in closely related natural products including 
myrtucommulone D (14) (Scheme 4).20,21
In line with recent literature describing asymmetric annulations between quinone methides 
and cyclic 1,3-dicarbonyls,22,23 we also explored an alternative three-component coupling 
approach toward the synthesis of rhodomyrtosone B (2) (Scheme 4). We found that 
treatment of a mixture of acylphloroglucinol 7, dimethyl acetal 15, and syncarpic acid 10 
with 20 mol % of scandium (III) triflate and camphorsulfonic acid (CSA) in refluxing 
isopropanol generated the natural product 2 in a single step. While the reaction still proceeds 
if only a Lewis acid or a Brønsted acid was used, a modest increase in yield was observed by 
using both in a cooperative manner. A plausible reaction mechanism is proposed in Scheme 
5. Acylphloroglucinol 7 first condenses with dimethyl acetal 15 derived from 
isovaleraldehyde to generate the benzylic methyl ether 16. In the presence of acid and heat, 
the methyl ether may be extruded to produce quinone methides 17/18. We believe quinone 
methide 18, likely activated by complexation with Sc(OTf)3, is a more relevant tautomeric 
form as its increased conjugation affords greater stability relative to 17. Quinone methide 18 
then engages with vinylogous ester 19 (derived from the condensation of syncarpic acid 10 
and isopropanol)24 thereby forming the tricyclic acetal 20 which subsequently loses 
isopropanol to afford 2. It is possible that the annulations proceed via cycloaddition; 
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however, literature reports on quinone methide annulations also propose stepwise 
mechanisms.26,27
Alternatively, we considered that syncarpic acid (10) may be acting as the relevant 
nucleophile and may condense with the oxocarbenium to form monoalkylidene 6, similar to 
our previous approach (cf. Table 1). Using the reaction conditions shown in Scheme 4, we 
tested this possibility by running two control experiments: one without the 
acylphloroglucinol 7 and one without syncarpic acid (10) (Scheme 6). We found that in the 
absence of 7, syncarpic acid (10) was quickly converted to vinylogous ester 19, but minimal 
condensation was observed. On the other hand, in the absence of syncarpic acid (10), 
acylphloroglucinol 7 completely reacted with dimethyl acetal 15 to form the quinone 
methide (cf. 17 in Scheme 5). The quinone methide was subsequently reduced25 in the 
presence of Lewis acid and isopropanol, cleanly affording the alkylated phenol 21 which 
could be isolated in excellent yield. The latter reaction conditions represent a promising and 
mild reductive transformation for alkylation of electron-rich arenes. These control 
experiments strongly support a mechanism for the three-component coupling (cf. Scheme 4) 
in which quinone methide formation precedes the annulation step.
After successfully synthesizing rhodomyrtosone B (2), we next turned our attention to the 
synthesis of rhodomyrtosone A (3). Specifically, we wished to prepare endoperoxide 8 as 
the penultimate intermediate in the synthesis of 3 (Scheme 7). This was achieved using flow 
photochemistry26 employing mono-alkylidene 6 using oxygen-saturated methanol as solvent 
to provide a 50% yield of endoperoxide27 8 as a mixture of diastereomers. The 
stereochemistry of endoperoxide 8 was not assigned due to its labile nature and as its 
configuration was inconsequential for the subsequent cyclization step. Endoperoxide 8 and 
acylphloroglucinol 7 were subsequently thermolyzed in acetic acid (100 °C) which afforded 
the bis-furan rhodomyrtosone A (3) in 60% yield. A proposed mechanism for the acid-
mediated formation of 3 is shown in Scheme 8. Treatment of peroxy acetal 8 with acid 
promotes the formation of the endocyclic peroxycarbenium ion 2428 via protonated 
intermediate 23. Interception of the putative peroxocarbenium intermediate 23 with 
acylphloroglucinol 7 may generate endoperoxide adduct 25. This peroxide may then 
undergo a Kornblum–DeLaMare29-type opening to 1,4-diketone 26 which can further 
cyclize to bis-furan 3 under acidic conditions. It should be noted that the reaction sequence 
may also formally be reversed in which endocyclic peroxide cleavage may occur prior to 
nucleophilic addition of the acylphloroglucinol.
CONCLUSION
In summary, we have developed a Ni (II)-mediated 1,4-addition of acylphloroglucinols to a 
syncarpic acid-derived alkylidene as a Michael acceptor to access the natural product 
rhodomyrtosone B after selective dehydrative cyclization. A three-component coupling 
strategy using a quinone methide intermediate was also found to be effective. In addition, 
oxygenation of a dienol derived from the same alkylidene scaffold permitted access to an 
endoperoxide intermediate which was utilized in a short synthesis of the bis-furan natural 
product rhodomytosone A. Further studies on the synthesis and biological properties of 
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1H NMR spectra were recorded at either at 400 or 500 MHz (as noted) at ambient 
temperature with CDCl3 as the solvent unless otherwise stated. 13C NMR spectra were 
recorded either at 100.0 or 125.0 MHz (as noted) at ambient temperature with complete 
proton decoupling using CDCl3 as the solvent unless otherwise stated. Infrared spectra were 
recorded on a FT-IR spectrophotometer. High-resolution mass spectra (HRMS) was carried 
out with electrospray ionization (ESI) using a Q-TOF mass spectrometer. Melting points 
were recorded on a Mel-temp apparatus. Analytical thin-layer chromatography (TLC) was 
performed using 0.25 mm silica gel 60-F plates. Preparative TLC was conducted with glass 
backed 1000 µm silica gel 60-F plates. Flash chromatography was performed using 200–400 
mesh silica gel. Photochemistry experiments were performed using a Hanovia 450 W 
medium pressure mercury lamp housed in quartz immersion cooler with a system circulator. 
Analytical LC-MS was performed on a UPLC (Ultra Performance Liquid Chromatography) 
with a Binary solvent manager, SQ mass spectrometer, PhotoDiode Array detector, and 
ELSD (Evaporative Light Scattering Detector). An Acquity UPLC BEH C18 1.7 µm column 
was used for analytical UPLC-MS. Yields refer to chromatographically and 
spectroscopically pure materials, unless otherwise stated. All reactions were carried out in 
flame-dried glassware under an argon atmosphere unless otherwise noted. Syncarpic acid 
(10)30 and acylphloroglucinol 731,32 were prepared using literature procedures.
5-Hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(pyrrolidin-1-yl)-butyl)cyclohex-4-
ene-1,3-dione (9)—To a flask was added syncarpic acid 10, (500 mg, 3 mmol, 1 equiv) 
and anhydrous diethyl ether (45 mL). The resulting solution was cooled to 0 °C, and 
pyrrolidine (275 µL, 3.29 mmol, 1.2 equiv) was added dropwise followed by the addition of 
isovaleraldehyde (370 µL, 3.43 mmol, 1.25 equiv). The solution became slightly cloudy. 
The reaction was stirred at 0 °C until a white precipitate was formed (about 30 min). The 
white solid was filtered and washed with cold ether and dried in vacuo to yield 9 as a white 
powder (800 mg, 90%). Rf: 0.44 hexanes:EtOAc:MeOH (1:1:0.1). Mp: 165–168 °C (diethyl 
ether), IR (thin film): 2974.01, 1698.89, 1583.04, 1470.19, 1455.19, 1410.05, 1366.04, 
1296.99, 1215.98 cm−1, 1H NMR (CDCl3, 500 MHz): δ 4.43 (d, J = 9.9 Hz, 1 H); 3.66–3.51 
(ddd, J = 2.70, 5.98, 10.44, 1H); 3.07–2.88 (m, 1 H); 2.89–2.71 (m, 1H); 2.23–2.08 (m, 1H); 
2.08–1.86 (m, 5H); 1.53–1.34 (m, 2H); 1.34–1.22 (m,12 H); 0.96–0.87 (m, 4 H); 0.87–0.75 
(m, 3H) 13C NMR (CDCl3, 125.67 MHz): δ 216.9, 98.7, 69.4, 54.1, 48.9, 32., 25.3, 24.5, 
22.6, 20.4, 17.5 ppm HRMS-ESI (m/z): [M + H]+ calculated for C19H32NO3, 322.2382; 
found, 322.2384
2,2,4,4-Tetramethyl-6-(3-methylbutylidene)cyclohexane-1,3,5-trione (6)—To a 
flask was added adduct 9 (200 mg, 0.62 mmol), and then methylene chloride was added (15 
mL, 0.04 M). A 1 M solution of hydrochloric acid in water was prepared and saturated with 
ammonium chloride. This solution was added to the reaction mixture. The mixture was 
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vigorously stirred at room temperature for 1h. The organic layer was washed with saturated 
brine (3×), and the organic fractions were dried over anhydrous sodium sulfate. Solvents 
were concentrated in vacuo to yield compound 6 (116 mg, 75%) as a pale yellow oil. Rf: 0.6 
hexanes:EtOAc (3:1), IR (thin film): 2965.63, 1695.43, 1606.38, 1465.51, 1383.58, 1296.07, 
1215.98, 1132.50, 1039.52 cm−1, 1H NMR (CDCl3, 500 MHz): δ 7.52 (t, J = 7.6 Hz, 1H), 
2.61 (t, J = 7.3 Hz, 2H), 1.89 (ddt, J = 13.5, 10.8, 6.8 Hz, 1H), 1.31–1.23 (m, 12 H); 0.97 (d, 
J = 6.7 Hz, 6H) 13C NMR (CDCl3, 125.67 MHz): δ 208.9, 199.5, 196.4, 159.1, 133.1, 58.5, 
57.9, 38.9, 35.6, 28.7, 22.5, 22.3, 21.9, HRMS-ESI (m/z): [M + H]+ calculated for 
C15H23O3, 251.1647; found, 251.1647
5-Hydroxy-2,2,6,6-tetramethyl-4-(3-methyl-1-(2,4,6-trihydroxy-3-(3-
methylbutanoyl)phenyl)butyl)cyclohex-4-ene-1,3-dione (5)—The dichloromethane 
and acetic acid used in this reaction were degassed three times using the freeze–pump–thaw 
method. To the acyl phloroglucinol 7 (25 mg, 0.12 mmol, 1.5 equiv) was added 
Ni(ClO4)2·6H2O (2.9 mg, 0.0080 mmol, 0.1 equiv) and methylene chloride (2 mL) at room 
temperature under argon followed by addition of 4 Å MS (20 mg). Next, a solution of 
monoalkylidene 6 (20 mg, 0.08 mmol, 1 equiv) in dichloromethane (1 mL) was added to the 
reaction mixture followed by acetic acid (0.5 mL). The reaction was stirred at room 
temperature for 5 h and heated to 40 °C for 12 h. The reaction was quenched with water and 
a solution of 1 M KHSO4 at 0 °C until reaching a pH ≈ 2. The reaction mixture was 
extracted with CH2Cl2 and washed with saturated brine. Organic fractions were gathered 
and dried over anhydrous sodium sulfate. Solvents were evaporated in vacuo yielding a 
yellow oil. Column chromatography purification on silica gel with a gradient of CH2Cl2: 
MeOH (90:1 to 20:1) provided 29 mg (0.06 mmol) of compound 5 in 80% yield. Mp: 51–54 
°C (hexanes, MeOH), IR (thin film): 2958.19, 2872.19, 1716.58, 1622.77, 1594.68, 1467.34, 
1383.88, 1367.29, 1300.61, 1215.23, 1118.62, 754.18 cm−1, 1H NMR (CDCl3, 500 MHz): δ 
0.83 (q, J = 5 Hz, 6H), 0.97 (d, J = 5 Hz, 6H), 1.23 (s, 3H), 1.31 (d, J = 5 Hz, 3H), 1.36 (d, J 
= 5 Hz, 3H), 1.42 (broad m, 1H), 1.47 (s, 3H), 1.75 (m, J = 10 Hz, 1H), 2.06 (m, J = 10 Hz, 
1H), 2.25 (m, J = 10 Hz, 1H), 2.95 (d, J = 5 Hz, 2H), 4.34 (t, J = 10 Hz, 1H), 5.86 (s, 2/3H) 
and 5.92 (s, 1/3H), 10.28 (s, 2/3H) and 10.55 (s, 1/3H); 11.15 (s, 1/3H) and 11.57 (s, 
2/3H), 13C NMR (CDCl3, 125.67 MHz): δ 22.5, 22.8, 23.1, 24.5, 25.5, 26.4, 27.1, 28.2, 
29.6, 29.9, 38.4, 48.9, 52.4, 55.3, 98.2, 109.5, 114.9, 158.6, 176.8, 203.4, 206.4, 212.5, 
HRMS-ESI (m/z): [M + H]+ calculated for C26H37O7, 461.2539; found, 461.2534.
Rhodomyrtosone B (2) from Compound 5—To a solution of compound 5 (20 mg, 
0.043 mmol, 1 equiv) in hexafluoroisopropanol (0.2 mL) was added trifluoroacetic acid 
(0.05 mL, 14 equiv) at room temperature. The reaction was stirred at 60 °C for 12 h. Then, 
the reaction was diluted with water and saturated brine, and the mixture was extracted with 
ethyl acetate (3 × 1 mL). The organic fractions were dried over anhydrous sodium sulfate, 
and solvents were evaporated in vacuo to yield a yellow solid. Purification using column 
chromatography on silica gel with a hexane:acetone gradient (12:1 to 4:1) provided 8 mg 
(0.018 mmol) of rhodomyrtosone B 2 (42% yield). Rf: 0.4 hexanes: acetone (3:1), Mp: 58–
62 °C IR (thin film): 3359.86, 2959.21, 2925.37, 2869.81, 1719.44, 1656.43, 1625.75, 
1597.94, 1504.38, 1469.46, 1431.80, 1388.20, 1368.12, 1255.28, 1161.24, 1121.96, 
1041.55, 1015.89 cm−1, 1H NMR (CDCl3, 500 MHz): δ 13.46 (s, OH), 6.26 (s, OH), 4.30 (t, 
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J = 6.1 Hz, 1H), 3.24–2.89 (m, 2H), 2.36 (dd, J = 13.2, 6.6 Hz, 1H), 1.64 (s, 3H), 1.47 (s, 
3H), 1.43 (s, 3H), 1.39 (s, 3H), 1.39–1.31 (m, 4H), 1.02 (dd, J = 14.3, 6.6 Hz, 6H), 0.87 (dd, 
J = 8.5, 6.4 Hz, 6H), 13C NMR (CDCl3, 125.67 MHz): δ 211.7, 203.9, 198.3, 167.2, 164.2, 
159.5, 153.1, 114.5, 105.9, 105.5, 100.2, 56.1, 53.4, 47.2, 46.9, 25.3, 25.0, 24.7, 24.7, 24.5, 
24.4, 24.2, 23.4, 23.1, 22.9, 22.6, HRMS-ESI (m/z): [M + H]+ calculated for C26H35O6 
443.2434; found, 443.2427
Rhodomyrtosone B (2) (Three-Component Reaction)—Acylphloroglucinol 7 (25 
mg, 0.119 mmol), dimethyl acetal 15 (16 mg, 0.119 mmol), and syncarpic acid 10 (22 mg, 
0.119 mmol) were suspended in dry isopropanol (1 mL). Camphorsulfonic acid (6 mg, 0.2 
equiv) was added followed by the addition of scandium(III) triflate (12 mg, 0.2 equiv). The 
mixture was heated to 80 °C for 6 h and was then cooled to room temperature. The reaction 
was quenched with saturated sodium bicarbonate solution (3 mL) and diluted with ethyl 
acetate (5 mL). The organic phase was removed, and the aqueous phase was extracted with 
ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine and dried 
over sodium sulfate before being concentrated under vacuum. The resulting crude oil was 
then purified by silica gel chromatography eluting with 10% ethyl acetate in hexanes to 
provide compound 2 (23 mg, 42% yield).
5-Isopropoxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione (19)—Syncarpic acid 
10 (22 mg, 0.119 mmol) and dimethyl acetal 15 (16 mg, 0.119 mmol) were suspended in dry 
isopropanol (1 mL). Camphorsulfonic acid (6 mg, 0.2 equiv) was added followed by the 
addition of scandium(III) triflate (12 mg, 0.2 equiv). The solution was then heated to 80 °C 
for 12 h. The reaction mixture was then cooled to room temperature and quenched with 
sodium bicarbonate solution (3 mL) and diluted with ethyl acetate (5 mL). The organic 
phase was removed, and the aqueous phase was extracted with ethyl acetate (3 × 5 mL). The 
combined organic layers were washed with brine and dried over sodium sulfate before being 
concentrated under vacuum. The crude oil was purified by silica gel chromatography 
yielding compound 19 as a clear liquid (12 mg, 44% yield). IR (thin film): 2980.8, 2928.6, 
1714.6, 1653.8, 1604.1, 1471.0, 1378.2, 1236.1, 1178.4, 1106.4,1042.7, 926.3 cm−1; 1H 
NMR (CDCl3, 500 MHz): δ 5.41 (s, 1H), 4.47 (sep, J = 6.1 Hz, 1H), 1.34–1.26 (m, 
18H); 13C NMR (CDCl3, 100 MHz): δ 213.4, 199.3, 176.4, 99.6, 71.3, 55.0, 48.0, 24.9, 
24.2, 21.1 ; HRMS-ESI (m/z): [M + H]+ calculated for C13H21O3; 225.1485 found, 
225.1483
3-Methyl-1-(2,4,6-trihydroxy-3-isopentylphenyl)butan-1-one (21)—
Acylphloroglucinol 7 (25 mg, 0.119 mmol) and dimethyl acetal 15 (16 mg, 0.119 mmol) 
were suspended in dry isopropanol (1 mL). Camphorsulfonic acid (6 mg, 0.2 equiv) was 
added followed by the addition of scandium(III) triflate (12 mg, 0.2 equiv). The mixture was 
heated to 80 °C for 6 h and was then cooled to room temperature. The reaction was then 
quenched with saturated sodium bicarbonate solution (3 mL) and diluted with ethyl acetate 
(5 mL). The organic phase was removed, and the aqueous phase was extracted with ethyl 
acetate (3 × 5 mL). The combined organic layers were washed with brine and dried over 
sodium sulfate before being concentrated under vacuum. The resulting crude oil was then 
purified on silica using 10% ethyl acetate in hexanes to provide compound 21, which was a 
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white oil (32 mg, 95% yield). IR(thin film): 2955.8, 2560 (br), 1609.4, 1579.8, 1522.9, 
1301.6, 1214.9, 1094.9 cm−1; 1H NMR (methanol-d4, 500 MHz): δ 5.90 (s, 1H), 2.94 (d, J = 
6.8 Hz, 2H), 2.56–2.49 (m, 2H), 2.24 (dt, J = 13.4, 6.7 Hz, 1H), 1.57 (dt, J = 13.2, 6.6 Hz, 1 
H), 1.40–1.32 (m, 2H), 0.97 (dd, J = 12.2, 6.6 Hz, 13 H); 13C NMR (MeOD, 100 MHz): δ 
207.9, 166.0, 164.6, 162.1, 110.0, 106.3, 95.7, 54.7, 40.2, 30.3, 27.7, 24.1, 24.0, 22.0 ; 
HRMS-ESI (m/z): [M + H]+ calculated for C16H25O4; 281.1747 found, 281.1759
8a-Hydroxy-3-isopropyl-6,6,8,8-tetramethyl-8,8a-dihydrobenzo-[c]
[1,2]dioxine-5,7(3H,6H)-dione (8)—A 0.01 M solution of alkylidene 6 (80 mg, 0.32 
mmol) was prepared in 32 mL of methanol in a flamed dried flask under argon at room 
temperature. A balloon of oxygen was bubbled through the solution for 30 min. The reaction 
flask with a balloon of oxygen bubbling through was connected to the flow setup. This setup 
employed Idex Health Science PFA (perfluoroalkoxyalkane) tubing (ID 0.062 in, OD 0.125 
in, 500 psi max pressure) looped tightly around the Hanovia lamp which was then placed in 
a chiller. The reactor was 1.614 m in length, and the total volume was 3.1 mL. A 
recirculating chiller maintained the flow reactor at −10 °C, and a fan ensured proper air 
circulation in the photobox to maintain the overall temperature of the reaction mixture in the 
system at 23 °C. The optimal flow rate determined and used was 0.5 mL/min. After the 
entire solution was consumed, the system was flushed with an additional 5 mL of methanol, 
and the receiving flask was replaced by a waste container. Irradiation was stopped, and the 
entire flow setup was flushed with benzene. The solution contained in the receiving flask 
was collected and the solvent was evaporated. Purification using column chromatography 
over silica gel using a gradient of hexanes:acetone (20:1 to 10:1) provided 45 mg (50%) of 
endoperoxides 8 as a 1:1 mixture or diastereomers (stereochemistry unassigned).
Diastereomer 1: Rf: 0.67 hexanes:EtOAc (2:1), Mp: 115–120 °C (CH2Cl2, MeOH), IR (thin 
film): 3408.97, 2975.64, 1726.15, 1690.59, 1633.86, 1469.19, 1377.38, 1286.22, 1216.22, 
1159.82.11, 1100.16 cm-1, 1H NMR (500 MHz, chloroform-d) δ 7.29 (d, J = 1.6 Hz, 1H), 
4.74 (dd, J = 5.9, 1.6 Hz, 1H), 3.51 (s, 1H), 2.03 (dt, J = 13.4, 6.8 Hz, 1H), 1.38 (d, J = 8.1 
Hz, 7H), 1.31 (s, 3H), 1.06 (dd, J = 6.8, 1.4 Hz, 7H), 1.03 (s, 3H). 13C NMR (126 MHz, 
cdcl3) δ 210.5, 197.5, 137.9, 134.3, 97.9, 83.5, 54.9, 51.7, 30.5, 26.6, 24.1, 20.7, 18.2, 17.9, 
15.1., HRMS-ESI (m/z): [M + H]+ calculated for C15H23O5, 283.1545; found, 265.1440 [M
+H–H2O]+
Diastereomer 2: Rf: 0.38 hexanes:acetone (2:1), IR (thin film): 3000.50, 2933.43, 2872.53, 
1693.60, 1638.03, 1470.98, 1375.00, 1262.55, 1187.51, 1131.25, 1100.01 cm-1, 1H NMR 
(500 MHz, chloroform-d): δ 7.43 (d, J = 4.1 Hz, 1H), 4.13 (dd, J = 8.3, 4.1 Hz, 1H), 3.62 (s, 
1H), 2.19–2.09 (m, 1H), 1.43 (s, 3H), 1.39 (d, J = 5.4 Hz, 6H), 1.33 (d, J = 3.4 Hz, 3H), 0.97 
(d, J = 6.7 Hz, 6H), 13C NMR (126 MHz, CDCl3): δ 207.1, 197.9, 137.9, 97.6, 85.0, 32.2, 
31.1, 30.1, 29.9, 26.8, 24.2, 21.1, 20.0, 19.2, 15.3., HRMS-ESI (m/z): [M + H]+ calculated 
for C15H23O5, 283.1545; found, 283.1547
Rhodomyrtosone A (3)—A solution of endoperoxides 8 (1:1 mixture of diastereomers) 
(6 mg, 0.021 mmol) in acetic acid 1 mL was transferred in a sealed tube and heated at 100 
°C for 12 h. Then the reaction mixture was diluted with water and quenched with a saturated 
sodium bicarbonate solution. The pH was kept slightly acidic. The reaction mixture was 
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extracted with ethyl acetate (3 × 5 mL), and the organic fractions were gathered and dried 
over anhydrous sodium sulfate. The solvents were evaporated in vacuo to yield a dark 
yellow oil. Purification by column chromatography over silica gel provided 6 mg (60%) of 3 
as a pale yellow gum. Rf: 0.7 hexanes:EtOAc 1:1, IR (thin film): 2960.88, 2930.37, 2873.99, 
1720.40, 1649.79, 122.93, 1469.93, 1420.62, 1384.14, 1305.44, 1215.98, 1171.78, 1052.58, 
921.63 cm−1, 1H NMR (500 MHz, CDCl3): δ 13.27 (s, 1H), 9.79 (s, 1H), 6.11 (s, 1H), 4.49 
(s, 1H), 2.96 (dd, J = 14.7, 6.6 Hz, 1H), 2.76 (dd, J = 14.7, 7.2 Hz, 1H), 2.40 (d, J = 6.8 Hz, 
1H), 2.17(m, J = 6.6 Hz, 1H) 1.52 (s, 3H), 1.42 (d, J = 5.3 Hz, 6H), 1.34 (s, 3H), 1.10 (dd, J 
= 11.8, 6.8 Hz, 6H), 1.00 (dd, J = 10.8, 6.7 Hz, 6H), 13C NMR (126 MHz, CDCl3): δ 211.3, 
203.8, 198.5, 179.8, 166.8, 159.9, 159.8, 129.5, 113.3, 104.3, 101.8, 99.7, 55.3, 51.69, 45.8, 
45.1, 35.5, 26.1, 24.5, 24.3, 23.3, 22.9, 22.9, 15.9, 15.9. HRMS-ESI (m/z): [M + H]+ 
calculated for C26H32O7; 457.2226 found, 457.2218
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Rhodomyrtone A and related natural products.
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Retrosynthetic analyses for rhodomyrtone A and rhodomyrtosone A.
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X-ray crystal structure of adduct 5.
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Synthesis of a Monoalkylidene Reaction Partner
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Dehydrative Cyclization of 5 to 2
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Model for Selective Formation of 2
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Quinone Methide Annulation Strategy towards 2
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Proposed Mechanism for Formation of 2 via Quinone Methides 17/18
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Control Experiments Probing the Mechanism of the Three-Component Coupling
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Synthesis of 3 via Endoperoxide 8
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Proposed Mechanism for the Formation of 3
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Table 1
Evaluation of the Conjugate Addition under Lewis Acidic Conditions
entrya Lewis acid 5:8c 5 (%)b
1 no catalyst 1:2.7 9
2 YbCl3 1.15:1 38
3 FeCl3 1.3:1 36
4 Yb(OTf)3 1:3.3 16
5 Gd(OTf)3 1:2.4 29
6 Lu(OTf)3 1:1.7 17
7 Cu(ClO4)2 1:4.3 6
8 Mg(ClO4)2 N/A 0
9 Zn(ClO4)2 N/A 0
10 PdCl2(PhCN)2 N/A 19
11 Ni(ClO4)2·6H2O 4.6:1 74
12 Ni(ClO4)2·6H2O (7 mol %) CH2Cl2:AcOH (6:1) 2.8:1 80
13d Ni(ClO4)2·6H2O (7 mol %) CH2Cl2:AcOH (6:1) 1:0 90
a
Reactions conducted with monoalkylidene 6 (1 equiv) and acylphloroglucinol 7 (1.5 equiv) in 1 mL of CH2Cl2.
b
Yields reported after isolation by silica gel column chromatography.
cCompound 8 was the only byproduct observed after complete consumption of starting materials. Ratio was determined after isolating both 
products.
dSolvents were thoroughly degassed using the freeze–pump–thaw method.
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